Metric Snapshot
- Latest value
- -118%
- Coverage range
- 31 Dec 2019 - 31 Mar 2024
- Fact rows
- 23
Shareable Research Card
Deciphera Pharmaceuticals, Inc. Operating Margin
This metric view shows Deciphera Pharmaceuticals, Inc. operating margin history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q1 2024
- Latest reported value
- -118%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Financial Metric Page
Deciphera Pharmaceuticals, Inc.: Operating Margin
Latest period: Q1 2024. Period end: 31 Mar 2024. Units: %. Frequency: quarterly and annual.
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
What This Metric Tells You
- Shows the reported level of operating margin over 31 Dec 2019 - 31 Mar 2024.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 23 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Operating Margin levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | Global Warming Solutions, Inc. (["gwso"]) | 99905400% | Quarter - 30 Sep 2022 | Open Global Warming Solutions, Inc. Operating Margin |
| 2 | NAMI Corp. ([]) | 1080289% | Quarter - 31 Mar 2021 | Open NAMI Corp. Operating Margin |
| 3 | PharmaCyte Biotech, Inc. (["pmcb"]) | 396584% | Quarter - 31 Jan 2014 | Open PharmaCyte Biotech, Inc. Operating Margin |
| 4 | ALR Technologies SG Ltd. (["alrtf"]) | 180380% | Year - 31 Dec 2022 | Open ALR Technologies SG Ltd. Operating Margin |
| 5 | MUSTANG BIO, INC. (["mbio"]) | 83624% | Quarter - 30 Sep 2019 | Open MUSTANG BIO, INC. Operating Margin |
| 6 | DOMINION ENERGY SOUTH CAROLINA, INC. ([]) | 63100% | Quarter - 31 Dec 2020 | Open DOMINION ENERGY SOUTH CAROLINA, INC. Operating Margin |
Metric Details
- Metric
- Operating Margin (OperatingMargin)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 31 Dec 2019 - 31 Mar 2024
- Facts on this page
- 23
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
Deciphera Pharmaceuticals, Inc. Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q1 2024 | -118% | +19% | +14% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -129% | +7.2% | +5.3% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -137% | +47% | +26% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -137% | +100% | +42% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -137% | +148% | +52% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -136% | +176% | +56% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -184% | +117% | +39% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -237% | +72% | +23% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -285% | +98% | +26% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -312% | +332% | +52% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -300% | +932% | +76% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -310% | +3506% | +92% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -383% | +522% | +58% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -644% | +159% | +20% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -1233% | 01 Jul 2020 | 30 Sep 2020 | ||
| Q2 2020 | -3816% | 01 Apr 2020 | 30 Jun 2020 | ||
| Q1 2020 | -906% | 01 Jan 2020 | 31 Mar 2020 | ||
| Q4 2019 | -803% | 01 Oct 2019 | 31 Dec 2019 |
Deciphera Pharmaceuticals, Inc. Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2023 | -129% | +7.2% | +5.3% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -136% | +176% | +56% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -312% | +332% | +52% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -644% | +159% | +20% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -803% | 01 Jan 2019 | 31 Dec 2019 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.